Table 2 Adjusted and unadjusted odds ratios (ORs with 95% CI) of a negative IgG test result after at least two doses of COVID-19 vaccine for individuals in the primary care cohort (Model A)

From: Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland

Risk Factors (Reference)

Odds Ratios (95% CI)

Unadjusted

Adjusted

Care Home Resident (No)

Yes

1.81 (1.07–3.06)

1.02 (0.55–1.89)

Shielding (No)

Yes

2.38 (2.05–2.76)

1.68 (1.38–2.04)

Immunosuppressed (No)

Yes

1.22 (0.99–1.50)

1.05 (0.83–1.33)

Severely

2.66 (2.23–3.17)

2.25 (1.80–2.83)

Prior SARs-CoV-2 Infection (No)

Yes

0.09 (0.06–0.15)

0.13 (0.08–0.21)

Number of QCOVID Risk Groups (0)

1

1.44 (1.25–1.67)

1.05 (0.89–1.24)

2

1.93 (1.63–2.29)

1.07 (0.88–1.31)

3-4

2.99 (2.51–3.57)

1.38 (1.11–1.72)

5+

4.72 (3.53–6.31)

1.94 (1.36–2.77)

BMI (18.5–25)

Unknown

0.75 (0.63–0.91)

1.12 (0.90–1.39)

<18.5

0.99 (0.59–1.69)

0.97 (0.53–1.76)

25-30

1.22 (1.01–1.48)

1.17 (0.94–1.45)

30+

1.49 (1.24–1.79)

1.55 (1.27–1.90)

SIMD (3)

1

1.02 (0.85–1.22)

0.95 (0.78–1.16)

2

1.06 (0.89–1.26)

1.03 (0.85–1.25)

4

0.95 (0.80–1.13)

1.04 (0.86–1.26)

5

0.92 (0.76–1.11)

1.00 (0.81–1.24)

Unknown

0.36 (0.11–1.15)

0.37 (0.11–1.23)

Sex (Female)

Male

1.10 (0.98–1.23)

1.06 (0.93–1.20)

Vaccine Dose (2 Doses Pfizer or Moderna)

Two doses of ChAdOx1

12.38 (10.06–15.24)

9.90 (7.87–12.45)

Mixed 3+ doses (including ChAdOx1)

0.60 (0.40–0.89)

0.68 (0.41–1.12)

Mixed 3+ doses (no ChAdOx1)

0.34 (0.20–0.60)

0.42 (0.23–0.77)

  1. For the adjusted ORs, we additionally adjust for age, days since first measurement and days since last vaccination as splines (see also Figure SB2).